Presentation TCT 2012 TCT-47. Two-year Clinical Outcome of the TWENTE Trial, A Randomized Controlled Trial Comparing Second-generation Zotarolimus-eluting Resolute Stents vs. Everolimus-eluting... Presenter: Clemens von Birgelen October 23, 2012
Presentation TCT 2012 First-in-Man Results with a Myolimus-Eluting Bioabsorbable PLLA-based Vascular Scaffold (Elixir DESolve) Presenter: Stefan Verheye October 23, 2012
Presentation TCT 2012 Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints(3) Presenter: Ian Meredith October 23, 2012
Presentation TCT 2012 New Insights into Normal and Diseased Mitral Valve Anatomy Presenter: David Adams October 23, 2012
Presentation TCT 2012 TCT-73. Non-Invasive Evaluation of Coronary Artery Collateral Flow Using Computed Tomographic Angiography Presenter: Jin-Ho Choi October 23, 2012
Presentation TCT 2012 OCT as a Clinical Tool for Vulnerable Plaque Detection: New Insights and Future Studies Presenter: Shiro Uemura October 23, 2012
Presentation TCT 2012 Hybrid Revascularization: The Emory Approach Presenter: John Puskas October 23, 2012
Presentation TCT 2012 Importance of Sustained Patency and the Role of DES for Infrapopliteal Intervention Presenter: Robert Lookstein October 23, 2012
Presentation TCT 2012 TCT-41. The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated with the Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and... Presenter: Giulio Stefanini October 23, 2012
Presentation TCT 2012 TCT-89. Timing, Predictive Factors and Prognostic Value of Cerebrovascular Events in a Large Cohort of Patients Undergoing Transcatheter Aortic Valve Implantation Presenter: Luis Nombela-Franco October 23, 2012